NAS10029,644+0.67%S&P7,651+0.17%GOLD$4,416+0.37%BTC$81,250+6.34%VIX14.81−4.08%live tape · as of 23:00 UTC · 18 Sep
The Screen · Technology · Semiconductors
KIOXIA HOLDINGS CORPORATION
285A.T · UNKNOWN · USD · Market cap $28.28T
Kioxia Holdings Corporation manufactures and sells memory and solid-state drives (SSDs) in Japan and internationally.
FAIL · Does not pass the screen
51,670.00 USD
At the last full screen 2026-09-03
Screened 2026-09-03 · the tape above runs as of 23:00 UTC · 18 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its markdown label.
KIOXIA HOLDINGS CORPORATION holds its Markdown at $51,670.00. Consolidating, no directional conviction, held for 3 days.
As held on the ledger · 2026-09-03
Phase
Markdown · caution
Quantitative state
Consolidating, no directional conviction, held for 3 days
Price at the screen
$51,670.00
Valuation
51.17 trailing · N/A forward price to earnings
Values screen
FAIL
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
33.96%
Below 33%
Interest-bearing debt is 34.0% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
5.94%
Below 33%
Cash held in interest-bearing accounts and securities is 5.9% of assets, under the one-third limit.
Pass
Receivables
30.66%
Below 49%
Money owed to the company is 30.7% of assets, under the 49% limit.
Pass
Revenue purity
0.41%
Below 5%
Only 0.4% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-09-03 screen. The gold marker is the market price at the same screen. A 35.0% margin of safety to the base estimate.
Third-party analyst targets: 16 covering, consensus Buy. The average target sits +114% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-03 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The risks · The things to watch: its business and earnings are exposed to Japan and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
285A.T trades on UNKNOWN (the company is based in Japan). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 7.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 269% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 3207%. Our forward projection puts the odds of a 10% gain over the next month near 69%. The street (15 analysts) rates it buy, with a mean price target of $60327.
2026-08-07Markup$56,010.00+0.0%Entry 13
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 269% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 3207%. Our forward projection puts the odds of a 10% gain over the next month near 69%. The street (15 analysts) rates it buy, with a mean price target of $60327. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-06Markup$56,010.00+0.0%Entry 12
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 269% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 3207%. Our forward projection puts the odds of a 10% gain over the next month near 69%. The street (15 analysts) rates it buy, with a mean price target of $60327. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-05Markup · changed$56,010.00+0.0%Entry 11
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 269% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 3207%. Our forward projection puts the odds of a 10% gain over the next month near 69%. The street (15 analysts) rates it buy, with a mean price target of $60327. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-04Distribution$56,010.00+0.0%Entry 10
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 269% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 3207%. Our forward projection puts the odds of a 10% gain over the next month near 69%. The street (15 analysts) rates it buy, with a mean price target of $60327. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 269% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 3207%. Our forward projection puts the odds of a 10% gain over the next month near 69%. The street (15 analysts) rates it buy, with a mean price target of $60327. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-02Markup$56,010.00+0.0%Entry 8
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 269% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 3207%. Our forward projection puts the odds of a 10% gain over the next month near 69%. The street (15 analysts) rates it buy, with a mean price target of $60327. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-01Markup$56,010.00+0.0%Entry 7
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 269% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 3207%. Our forward projection puts the odds of a 10% gain over the next month near 69%. The street (15 analysts) rates it buy, with a mean price target of $60327. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-31Markup$56,010.00+7.5%Entry 6
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 7.5% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 269% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 3207%. Our forward projection puts the odds of a 10% gain over the next month near 69%. The street (15 analysts) rates it buy, with a mean price target of $60327. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-19Markup$52,110.00-27.5%Entry 5
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 27.5% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 269% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 3207%. Our forward projection puts the odds of a 10% gain over the next month near 69%. The street (15 analysts) rates it buy, with a mean price target of $60327.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Latest News · What the Market Is Reading on 285A.T